Merck GHI (investor - Corporate Investor)
See something wrong or missing? Let us know
Merck Global Health Innovation Fund (GHI) is a corporate healthcare venture capital of Merck.
Average round investment:12.27M USD
Average number per year:1.0
Distribution:
2021 (1)2018 (1)2017 (1)
Portfolio companies:
Antidote
QuitGenius
Antidote
QuitGenius
Mostly invests in:
United Kingdom (3)
Health services (3)
United Kingdom (3)
Health services (3)
3 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Merck GHI
| Name | Criteria | |
|---|---|---|
![]() |
Accomplice
80%
|
|
![]() |
Global Emerging Markets
76%
|
|
![]() |
Smedvig Capital
76%
|
|
![]() |
Jeremy Yap
76%
|
|
![]() |
Monkfish Equity
75%
|
|
![]() |
Colle Capital Partners
74%
|
|
![]() |
Niklas Östberg
74%
|
|
![]() |
Learn Capital
74%
|
|
![]() |
MBA Mutuelle
74%
|
|
![]() |
Alter Equity
74%
|
|





Belgium
Netherlands
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain